The global adalimumab drugs market is expanding, driven by the growing focus on targeted therapies worldwide. Valued for its therapeutic impact, the market is projected to grow at a CAGR of 5.10% from 2025 to 2034, reflecting increasing adoption and innovation in biologic treatments across key regions. https://www.expertmarketresearch.com/reports/adalimumab-drugs-market